Stock listing
0R1B Stock Price, News, Filings & Events — Biogen Inc.
Selected listing: 0R1B · LSE · USD · GB
This page tracks Biogen Inc.'s 0R1B:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0R1B:LSE. 0R1B:LSE is the stock-level entry point for investors researching Biogen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biogen Inc. is a publicly traded biotechnology company based in America, with a market capitalization of approximately $29.4 billion. The company focuses on developing therapies for neurological diseases and has a strong portfolio of innovative treatments. Biogen is committed to advancing scientific research and improving patient outcomes in the field of neuroscience.
- Ticker
- 0R1B:LSE
- Asset type
- Stock
- Market cap
- $29.99B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
Biogen Inc. 0R1B:LSE stock context
This page tracks Biogen Inc.'s 0R1B:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0R1B:LSE. 0R1B:LSE is the stock-level entry point for investors researching Biogen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biogen Inc. is a publicly traded biotechnology company based in America, with a market capitalization of approximately $29.4 billion. The company focuses on developing therapies for neurological diseases and has a strong portfolio of innovative treatments. Biogen is committed to advancing scientific research and improving patient outcomes in the field of neuroscience.
Latest news from Biogen Inc.
Veeva Vault CRM Selected by Biogen
August 25, 2026
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
August 24, 2026
LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
August 24, 2026
Biogen : Reports Second Quarter 2026 Results
July 29, 2026
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide
July 16, 2026
Research Biogen Inc.
Biogen Inc. investor report
Review AI stock analysis and investor report context for 0R1B:LSE.
Biogen Inc. company profile
View the public company page for Biogen Inc. on 6ix.
Biogen Inc. news
Read company news and market updates connected to Biogen Inc..
Biogen Inc. investor events
Find investor webinars, events, and replay context for Biogen Inc..
Alternate listings
BIIB:NASDAQ
US · USD
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
IDP:GETTEX
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
BIIB:BCBA
AR · ARS
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
IDP:TRADEGATE
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
789617:LSX
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
BIIB:BMV
MX · MXN
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
BIIBD:BCBA
AR · USD
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
789617:LS
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
BIIB:BCS
CL · USD
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
IDP:FWB
DE · EUR
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
1BIIB:MIL
IT · EUR
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.
BIIB34:BMFBOVESPA
BR · BRL
Alternate listing for Biogen Inc.; the primary context on this page is 0R1B:LSE.